Join to View Full Profile
568 Via AmalfiIrving, TX 75039
Phone+1 817-291-3695
Dr. Drinkard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lee Drinkard is an oncologist at DHR Oncology Institute in Edinburg, TX. He received his medical degree from West Virginia University School of Medicine and has been in practice for 30 years. He specializes in Medical Oncology with special interests in clinical trials, drug development, thoracic, breast and hematologic oncology.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
George Washington UniversityResidency, Internal Medicine, 1987 - 1990
West Virginia University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1994 - Present
MO State Medical License 2024 - 2026
OH State Medical License 2024 - 2026
TX State Medical License 1997 - 2026
KS State Medical License 2024 - 2025
IL State Medical License 1990 - 2002
WV State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians American College of Physicians, 1995
Publications & Presentations
PubMed
- When Two Worlds Collide: A Rare Case of Multiple Myeloma With Extramedullary Plasmacytoma.Jorge Nadal Bosch, Mario Moya, Samuel Serna, Lee Drinkard, Javier Malcolm
Cureus. 2023-12-01 - 6 citationsHodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphomaJohn R. Krause, Lee C. Drinkard, Latoya Keglovits
Proceedings. 2013-01-01 - 9 citationsInduction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysisPhilip C. Hoffman, Daniel J. Haraf, Mark K. Ferguson, L. C. Drinkard, E. E E.Vokes
Annals of Oncology. 1998-06-01
Press Mentions
Oncologist, Fire Chief Stress Safety of COVID Vaccine for Cancer PatientsJanuary 6th, 2021
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
